Saito H, Scott J G, Movat H Z, Scialla S J
J Lab Clin Med. 1979 Aug;94(2):256-65.
We have studied plasmas of 49 individuals with homozygous Hageman trait from 42 kindreds, all of which contained less than 1% of the Hageman factor (factor XII) clotting activity of pooled normal plasmas. Forty-seven plasmas contained less than 1% of Hageman factor antigen. In two other, unrelated individuals with Hageman trait, nonfunctional material immunologically indistinguishable from normal Hageman factor was detected in plasma by radioimmunoassay at concentrations of 39% and 80%, respectively. These plasmas did not contain circulating anticoagulants against Hageman factor and, as in ordinary Hageman trait, displayed impaired surface-mediated plasma reactions such as fibrinolysis and kinin generation. Upon immunodiffusion against anti-Hageman factor serum, these plasmas formed a single precipitin line of complete identity with normal plasma or purified Hageman factor. Upon immunoelectrophoresis, the precipitin line had the same mobility as normal Hageman factor. Nonfunctional Hageman factor and normal Hageman factor behaved identically on a Sephadex G-150 column (apparent MW = 100,000) and on sucrose density-gradient centrifugation (4.5S). Nonfunctional Hageman factor was adsorbed to kaolin as readily as normal Hageman factor, suggesting that the binding site to negatively charged surfaces is different from functional sites. Antiserum raised against Hageman factor-like material in a CRM+ Hageman trait plasma specifically inactivated Hageman factor activity in normal plasma. The plasmas of three heterozygotes in these families contained approximately twice as much Hageman factor antigen as Hageman factor activity, whereas those of 16 heterozygotes in ordinary (CRM-) Hageman trait families contained approximately equal amounts of activity and antigen. The present study indicates that rarely homozygous Hageman trait may be CRM+ and that this defect is genetically determined.
我们研究了来自42个家族的49名纯合子哈格曼特征个体的血浆,所有这些个体的血浆中哈格曼因子(因子XII)的凝血活性均低于混合正常血浆的1%。47份血浆中哈格曼因子抗原含量低于1%。在另外两名无亲缘关系的具有哈格曼特征的个体中,通过放射免疫测定法在血浆中分别检测到浓度为39%和80%的与正常哈格曼因子免疫上无法区分的无功能物质。这些血浆中不含有针对哈格曼因子的循环抗凝剂,并且与普通哈格曼特征一样,表现出表面介导的血浆反应受损,如纤维蛋白溶解和激肽生成。用抗哈格曼因子血清进行免疫扩散时,这些血浆形成了一条与正常血浆或纯化的哈格曼因子完全相同的单一沉淀线。在免疫电泳中,沉淀线的迁移率与正常哈格曼因子相同。无功能的哈格曼因子和正常哈格曼因子在葡聚糖凝胶G - 150柱(表观分子量 = 100,000)和蔗糖密度梯度离心(4.5S)上表现相同。无功能的哈格曼因子与正常哈格曼因子一样容易吸附到高岭土上,这表明与带负电荷表面的结合位点不同于功能位点。针对CRM +哈格曼特征血浆中哈格曼因子样物质产生的抗血清能特异性灭活正常血浆中的哈格曼因子活性。这些家族中三名杂合子的血浆中哈格曼因子抗原含量约为哈格曼因子活性的两倍,而普通(CRM -)哈格曼特征家族中16名杂合子的血浆中活性和抗原含量大致相等。本研究表明,纯合子哈格曼特征很少可能是CRM +,并且这种缺陷是由基因决定的。